Patents Assigned to BIOTECH PHARMACEUTICAL CO. LTD.
  • Patent number: 10457747
    Abstract: Provided is a method for obtaining high-yield, stable expression cell clones from myeloma cell lines in a protein-free culture medium. The method is used for industrial production of a recombinant antibody, and includes three stage: (1) adapting to a protein-free culture medium, statically culturing cells at a low density, and gradually reducing a fat-rich supplement to a chemical culture medium; (2) adapting to a protein-free culture medium; culturing cells at a high density, and using a perfusion fermentation system in a laboratory scale; and (3) screening high-yield, stable expression cell clones from the cells after fermentation ends. The cell clone may be used to produce a humanized anti-NeuGcGM3 14F7 recombinant antibody.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: October 29, 2019
    Assignees: BIOTECH PHARMACEUTICAL CO. LTD., CENTRO DE INMUNOLOGIA MOLECULAR
    Inventors: MeyLen Chea, Julio Palacios, Miguel Arias, Loany Calvo, Tamara González, Rolando Pérez, Zhi Bai, Yuemao Liu, Kaiheng Xiao, Xiao Chen, Zhenhua He, Yangliu Cai, Zhenhua Yang, Xianhong Bai
  • Patent number: 8790738
    Abstract: A process of preparing a burdock composite micron essence at least includes the following. Dissolved and heated phospholipid is added to a vegetable oil extract and then stirred. After stirring, the above mixture is pour into a heated glycerol and then further stirred and a burdock extract aqueous solution is added. The aforementioned mixed solution is stirred at high speed, the emulsion-homogenized solution is subject to high-pressure homogenization, and a filtration membrane is used to filter the homogenized solution obtained to get a purple transparent burdock concentrate. The burdock concentrate is used to prepare the formulation of nano-micro emulsion which is easily absorbed by human body and thus grants improved health benefits.
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: July 29, 2014
    Assignee: Dong Yuan Biotech Pharmaceutical Co., Ltd
    Inventors: Tong-Rong Tsai, Hsueh-Chiao Liu
  • Publication number: 20130084380
    Abstract: A process of preparing a burdock composite micron essence at least includes the following. Dissolved and heated phospholipid is added to a vegetable oil extract and then stirred. After stirring, the above mixture is pour into a heated glycerol and then further stirred and a burdock extract aqueous solution is added. The aforementioned mixed solution is stirred at high speed, the emulsion-homogenized solution is subject to high-pressure homogenization, and a filtration membrane is used to filter the homogenized solution obtained to get a purple transparent burdock concentrate. The burdock concentrate is used to prepare the formulation of nano-micro emulsion which is easily absorbed by human body and thus grants improved health benefits.
    Type: Application
    Filed: July 23, 2012
    Publication date: April 4, 2013
    Applicant: DONG YUAN BIOTECH PHARMACEUTICAL CO.,LTD
    Inventors: Tong-Rong Tsai, Hsueh-Chiao Liu